MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1. 2019

Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
Department of Gastroenterology, Shanxi Academy of Medical Science, Shanxi Dayi Hospital Taiyuan, Shanxi Province, China.

Colon cancer is one of the most common malignancies worldwide, while the molecular mechanism remains largely unknown. miR-223-3p plays an important role in cancer development. Here, we found that miR-223-3p was up-regulated in 30 cases of colon cancer tissues as compared with their adjacent normal tissues. Lentivirus-mediated miR-223-3p over-expression promoted the proliferation, colony formation, migration and invasion of colon cancer cells. Inverse results were observed in miR-223-3p knockdown cells. Epithelial-mesenchymal transition (EMT) was regulated by miR-223-3p. In addition, cell apoptosis was suppressed and enhanced by miR-223-3p over-expression and knockdown, respectively. We further identified PRDM1, a tumor suppressor, was the target of miR-223-3p using microarray and luciferase assay. Our findings suggested that miR-223-3p acts as an oncogenic microRNA in colon cancer through regulating EMT and PRDM1.

UI MeSH Term Description Entries

Related Publications

Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
January 2022, Frontiers in oncology,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
April 2020, Cancer medicine,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
February 2020, Acta biochimica et biophysica Sinica,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
September 2019, International journal of molecular medicine,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
January 2021, Technology in cancer research & treatment,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
January 2020, OncoTargets and therapy,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
November 2019, Radiology and oncology,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
January 2021, Placenta,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
January 2024, OncoTargets and therapy,
Bao Chai, and Yarong Guo, and Xiangli Cui, and Jinchun Liu, and Yuhong Suo, and Zhangfeng Dou, and Ning Li
August 2018, Oncology letters,
Copied contents to your clipboard!